Multiple Sclerosis Drugs Market 2020 Global Industry Share, Regional Industry Outlook, Size, Growth and Forecast 2025 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Multiple Sclerosis Drugs Market 2020 Global Industry Share, Regional Industry Outlook, Size, Growth and Forecast 2025

Description:

The global multiple sclerosis drugs market is expected to gain from the development of economical therapy to treat multiple sclerosis (MS) – PowerPoint PPT presentation

Number of Views:21
Date added: 6 July 2020
Slides: 4
Provided by: diya5246
Category:

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Multiple Sclerosis Drugs Market 2020 Global Industry Share, Regional Industry Outlook, Size, Growth and Forecast 2025


1
The global multiple sclerosis drugs market is
expected to gain from the development of
economical therapy to treat multiple sclerosis
(MS), finds Fortune Business Insights in a
report, titled "MULTIPLE SCLEROSIS DRUGS GLOBAL
MARKET ANALYSIS, INSIGHTS AND FORECAST,
2019-2026." According to the report, the global
market was worth US 23,460.3 Mn in 2018. The
market is anticipated to expand at a CAGR of 6.7
and reach US 39,289.5 Mn by the end of 2026. The
report offers a comprehensive overview of the
global multiple sclerosis drugs market. The
research report gives an entire study of the
Multiple Sclerosis Drugs Market leaders with key
statistics like sales, revenue, price, product
picture and specifications, contact information,
cost, capacity, production and company profile.
The report offers critical information at the
state of the enterprise. Marketing channels and
development trends of the market is also
well-found inside the report, making it a
valuable source of information and path for
agencies and individuals. Key Stakeholders
Raw material suppliers
Distributors/traders/wholesalers/suppliers
Regulatory bodies, including government agencies
and NGO Commercial research and development
(RD) institutions Importers and exporters
Government organizations, research
organizations, and consulting firms Trade
associations and industry bodies End-use
industries Request a Sample Copy of the
Research Report https//www.fortunebusinessinsigh
ts.com/enauirv/reauest-sample-pdf/multiple-scleros
is-drugs-market-100386
Development of New Therapeutics to Propel
Growth In terms of route of administration, the
injection segment was leading the market in 2018
and is anticipated to expand considerably over
the forecast period. The growth witnessed is
attributable to the active government
recommendation for the injection. Development of
new therapeutics for treating multiple sclerosis
and rising awareness about the disease are a
expected to drive the global multiple sclerosis
drugs market. Additionally, increasing per-capita
income and increasing healthcare expenditure are
some factors anticipated to fuel the demand in
the global market. Leading Players operating in
the Multiple Sclerosis Drugs Market are
Biogen Pfizer, Inc. Hoffmann-La
Roche Ltd Merck Co., Inc. Novartis
AG Sanofi Teva Pharmaceutical
Industries Ltd. Other players Tecfidera's
Increasing Sale to Drive Biogen's Growth in
Global Market Biogen emerged as the leading
player in the global multiple sclerosis market in
2018, owing to the high sales of Tecfidera.
Biogen is expected to witness impressive growth
during the forecast period gaining from
strategical partnering with other players to
widen the distribution network. Besides this,
Novartis AG is also among the leading
organizations. Owing to high demand for Gilenya,
Novartis holds a strong position in the global
market. In 2018, the National Institute for
Health and Care Excellence announced to recommend
Extavia among other beta interferon drugs such as
Avonex, Betaferon and Rebif. This is anticipated
to contribute towards Novartis's market position.
Further, this is anticipated to fuel the demand
for multiple sclerosis treatment and drugs. Some
of the companies operating in the global
2
market are Pfizer, Inc., F. Hoffmann-La Roche
Ltd, Merck Co., Inc., Sanofi, and Teva
Pharmaceutical Industries Ltd. Have Any Query?
Ask Our Expertshttps//www.fortunebusinessinsiaht
s.com/enquirv/speak-to-analvst/multiple-sclerosis-
druas-market-100386 Segmentation of the Global
Multiple Sclerosis Drugs Market By Drug Class
Immunomodulators Immunosuppressants
Interferons Others By Route of
Administration Oral Injection o
Intramuscular o Subcutaneous o Intravenous By
Distribution Channels Hospital Pharmacy
Retail Pharmacy Online Stores By Geography
North America (USA and Canada) Europe
(UK, Germany, France, Italy, Spain, Scandinavia
and Rest of Europe) Asia Pacific (Japan,
China, India, Australia, Southeast Asia and Rest
of Asia Pacific) Latin America (Brazil,
Mexico and Rest of Latin America) Middle
East Africa (South Africa, GCC and Rest of
Middle East Africa) Order Full Report
https//www.fortunebusinessinsiahts.com/checkout-p
aae/100386 Reasons to Purchase this Report
Tracks the developments, such as new product
launches, agreements, mergers and acquisitions,
aeoaraphical expansions, and joint ventures.
Comprehensive analysis of the Aesthetic Implants
Market growth drivers, obstacles, opportunities,
and other related challenges. Identifies
market restraints and boosters. Identifies
all the possible segments present in the market
to aid organizations in strategic business
planning. Related Reports Mucopolysaccharidosis
Treatment Market 2020 Size. Regional Growth
Analysis, Industry Overview, Trends and Forecast
2026
Medical Carts Market 2020 Global Industry Update,
Size, Regional Trends, Industry Outlook and
Forecast 2026
3
Ocular Implants Market 2020 Global Industry
Share. Size, Regional Overview, Industry Supply
and Forecast 2026 About Us Fortune Business
Insights offers expert corporate analysis and
accurate data, helping organizations of all sizes
make timely decisions. We tailor innovative
solutions for our clients, assisting them to
address challenges distinct to their businesses.
Our goal is to empower our clients with holistic
market intelligence, giving a granular overview
of the market they are operating in. Our reports
contain a unique mix of tangible insights and
qualitative analysis to help companies achieve
sustainable growth. Our team of experienced
analysts and consultants use industry-leading
research tools and techniques to compile
comprehensive market studies, interspersed with
relevant data. At Fortune Business Insights we
aim at highlighting the most lucrative growth
opportunities for our clients. We, therefore,
offer recommendations, making it easier for them
to navigate through technological and
market-related changes. Our consulting services
are designed to help organizations identify
hidden opportunities and understand prevailing
competitive challenges. Contact Us Fortune
Business Insights Pvt. Ltd. 308, Supreme
Headquarters, Survey No. 36, Baner, Pune-Bangalore
Highway, Pune - 411045, Maharashtra,
India. Phone US 1 424 253 0390 UK 44 2071
939123 APAC 91 744 740 1245 Emailsales_at_fortune
businessinsights.com Fortune Business Insights
Linkedin Twitter BLogs
About PowerShow.com